crenolanib

crenolanib
Trade Name
Orphan Indication Acute myeloid leukemia
USA Market Approval USA
USA Designation Date 2012-10-31 00:00:00
Sponsor AROG Pharmaceuticals, LLC;12400 Coit Road, Suite 570;Dallas, Texas, 75251
Related Access Program
Children’s Hospital Los Angeles – Acute myeloid leukemia Jazz Pharmaceuticals – Secondary AML Celator Pharmaceuticals – Secondary AML University of California, San Francisco – Acute myeloid leukemia Emory University – Acute myeloid leukemia